Yıl: 2022 Cilt: 19 Sayı: 2 Sayfa Aralığı: 250 - 256 Metin Dili: İngilizce DOI: 10.5152/jern.2022.83704 İndeks Tarihi: 04-07-2022

Pharmacotherapy and Nursing Approaches in Neonates

Öz:
Pharmacotherapy gains importance in newborns due to the differences in body physiology. Newborns need special drug treatments due to their anatomical, physiological, and biochemical differences that change the pharmacokinetics and pharmacodynamics of various drugs. Factors such as gastric pH and emptying time, intestinal transit time, immaturity of secretion, total body water, immaturity of the neurological and the urinary systems may result in age-related changes in pharmacokinetics and pharmacodynamics. Due to the immaturity of the body systems of the newborns, the absorption, distribution, metabolism, and excretion of the drugs from the body are different from that in adults. Knowing the pharmacokinetics of the drugs in medicaments and their appropriate treatment is of great importance in the prevention of drug errors. From these perspectives, neonatology nurses have crucial roles to play in providing patient safety in their care. The aim of this review is to develop a guide regarding the essential principles of pharmacokinetics in newborns and safe drug administrations. In this review, the newborn pharmacokinetics and nursing approaches are examined under three subtitles: (1) pharmacological definitions-principles, (2) pharmacokinetics in newborns, and (3) responsibilities of the nurse. It is expected that this study will guide neonatal nurses in practice and shed light for further research and new studies on pharmacotherapy and safe drug administrations.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Bucci-Rechtweg C. Enhancing the pediatric drug development framework to deliver better pediatric therapies tomorrow. Clin Ther. 2017;39(10):1920- 1932. [CrossRef]
  • 2. Hawcutt DB, Rose AC, Fuerst-Rectenwald S. Points to consider when planning the collection of blood or tissue samples in clinical trials of investigational medicinal products in children, infants and neonates. In: Rose K, van der Anker JW, eds. Guide to Pediatric Drug Development and Clinical Research. Switzerland: Karger; 2010:96-110.
  • 3. Tayman C, Rayyan M, Allegaert K. Neonatal pharmacology: extensive interindividual variability despite limited size. J Pediatr Pharmacol Ther. 2011;16(3):170-184. [CrossRef]
  • 4. Turner MA, Hirschfeld S. Frameworks for evaluating medicines in children. Clin Ther. 2017;39(10):1949-1958. [CrossRef]
  • 5. Ku LC, Smith PB. Dosing in neonates: special considerations in physiology and trial design. Pediatr Res. 2015;77(1-1):2-9. [CrossRef]
  • 6. Dağoğlu T,Görak G. Temel Neonatoloji ve Hemşirelik İlkeleri. İstanbul: Nobel Tıp Kitabevleri; 2009.
  • 7. Allegaert K, Van de Velde M, Van den Anker J. Neonatal clinical pharmacology. Paediatr Anaesth. 2014;24(1):30-38. [CrossRef]
  • 8. Wang J, Avant D, Green D, et al. A survey of neonatal pharmacokinetic and pharmacodynamic studies in pediatric drug development. Clin Pharmacol Ther. 2015;98(3):328-335. [CrossRef]
  • 9. Potts NL, Mandleco BL. Pediatric Nursing, Caring for Children and Their Families. 3nd ed. Delmor: Cengage Learning; 2012.
  • 10. Toruner E, Buyukgonenc L. Çocuk Sağlığı: Temel Hemşirelik Yaklaşımları. 1st ed. Ankara: Nobel Tıp Kitapevi; 2017.
  • 11. Boykova M, Kenner C. Use of a professional organization (Council of International Neonatal Nurses) for global networking. J Perinat Neonatal Nurs. 2010;24(2):182-186. [CrossRef]
  • 12. Plitteri A. Maternal & Child Health Nursing. 7th ed. China: Library of Congress; 2014:1560-1574.
  • 13. Bertsche T, Bertsche A, Krieg EM, et al. Prospective pilot intervention study to prevent medication errors in drugs administered to children by mouth or gastric tube: a programme for nurses, physicians and parents. Qual Saf Health Care. 2010;19(5):e26. [CrossRef]
  • 14. Ferranti J, Horvath M, Cozart H, Whitehurst J, Eckstrve J. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment. Pediatrics. 2008;121:1201-1207. [CrossRef]
  • 15. Poplin RA, Fox W, Abman SH. Fetal and Neonatal Physiology. 4th ed. Philadelphia: Elsevier Saunders; 2011.
  • 16. Johnson PJ. Neonatal pharmacology—pharmacokinetics. Neonatal Netw. 2011;30(1):54-61. [CrossRef]
  • 17. Glasper E, McEwing G, Richardson J. Oxford Handbook of Children’s & Young People’s Nursing. USA:Oxford University Press; 2015.
  • 18. Lu H, Rosenbaum S. Developmental pharmacokinetics in pediatric populations. J Pediatr Pharmacol Ther. 2014;19(4):262-276. [CrossRef]
  • 19. Bonate PL, Howard DR. Pharmacokinetics in Drug Development: Clinical Study Design and Analysis. USA:Pharmaceutical Scientists; 2016.
  • 20. Fernandez E, Perez R, Hernandez A, Tejada P, Arteta M, Ramos JT. Factors and mechanisms for pharmacokinetic differences between pediatric population and adults. Pharmaceutics. 2011; 3(1):53-72. [CrossRef]
  • 21. Bar-Shalom D, Ros K. Pediatric formulations: a roadmap. In: Jong G, ed. AAPS Advances in the Pharmaceutical Sciences Series Pediatric Development: Physiology. Enzymes, Drug Metabolism, Pharmacokinetics and Pharmacodynamics. Springer; London; 2014.
  • 22. O’Hara K, Wright IM, Schneider JJ, Jones AL, Martin JH. Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future. Br J Clin Pharmacol. 2015;80(6):1281-1288. [CrossRef]
  • 23. Leroux S, Turner MA, Guellec CB, et al. Pharmacokinetic studies in neonates: the utility of an opportunistic sampling design. Clin Pharmacokinet. 2015;54(12):1273-1285. [CrossRef]
  • 24. Ovalı F. Yenidoğan İlaç Rehberi. İstanbul: Nobel Matbaacılık; 2014. 25. Standing JF, Anderson BJ, Holford NHG, Lutsar I, Metsvaht T. Comment on pharmacokinetic studies in neonates: the utility of an opportunistic sampling design. Clin Pharmacokinet. 2015;54(12):1287-1288. [CrossRef]
  • 26. Kenner C, Lott J. Comprehensive Neonatal Nursing Care. 5th ed. New York: Springer Publishing Company; 2014.
  • 27. Yaffe SJ, Aranda JV. Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice. London: Lippincott Williams & Wilkins; 2010.
  • 28. Martin R, Fanaroff AA, Walsh MC. Fanaroff and Martin's Neonatal-Perinatal Medicine E-Book: Diseases of the Fetus and Infant. Philadelphia: Elsevier Saunders; 2015.
  • 29. Visscher MO. Update on the use of topical agents in neonates. Newborn Infant Nurs Rev. 2009;9(1):31-47. [CrossRef]
  • 30. Skinner AV. Neonatal pharmacology. Anaesth Intens Care Med. 2014;15(3):96- 102. [CrossRef]
  • 31. Gardner LS, Carter BS, Enzman-Hines M, Hernandez JA. Merenstein & Gardner’s Handbook of Neonatal Intensive Care. USA: Mosby, Elsevier; 2011.
  • 32. Kliegman RM, Geme III JWS. Nelson textbook of pediatrics e-book. In: Sandritter TL, Jones BL, eds. Principles of Drug Theraphy. Canada: Elsevier; 2020:445-455.
  • 33. Sethi A, Priyadarshi M, Agarwal R. Mineral and bone physiology in the foetus, preterm and full-term neonates. In: Semin Fetal Neonatal Med. 2020;25(1):101076. [CrossRef]
  • 34. Lutsar I, Trafojer UM, Heath PT, et al. Meropenem vs standard of care for treatment of late onset sepsis in children of less than 90 days of age: study protocol for a randomised controlled trial. Trials. 2011;12:215. [CrossRef]
  • 35. Gabay M. The. Clinical Practice of Drug Information. USA: Jones & Bartlett Learning; 2016.
  • 36. Kelly LE, Rieder M, Van den Anker J, et al. More codeine fatalities after tonsillectomy in NorthAmerican children. Pediatrics. 2012;129(5):e1343-e1347. [CrossRef]
  • 37. Martin L, Jimenez N, Lynn AM. Developmental pharmacokinetics and pharmacodynamics of parenteral opioids and nonsteroidal anti-nflammatory drugs in neonates and infants. Rev Colomb Anestesiol. 2017;45(1):72-79. [CrossRef]
  • 38. Charles B. Population pharmacokinetics: an overview. Aust Prescr. 2014;37(6):210-213. [CrossRef]
  • 39. Carballo-Magdaleno D, Guízar-Mendoza JM, Amador-Licona N, Domínguez- Domínguez V. Renal function, renal volume, and blood pressure in infants with antecedent of antenatal steroids. Pediatr Nephrol. 2011;26(10):1851- 1856. [CrossRef]
  • 40. Conk Z, Başbakkal Z, Bal-Yılmaz H, Bolışık B. Pediatri Hemşireliği. 1st ed. Ankara: Akademisyen Tıp Kitapevi; 2013.
  • 41. Toruner E, Erdemir F. Pediatrik Hastalarda İlaç Uygulama Hatalarının Önlenmesi. Hacettepe Univ Sağlık Bilimleri Fak Hemşirelik Derg. 2010;17(1):63-71. Available at: http: //www .hace ttepe hemsi relik dergi si.or g/pdf /pdf_ HHD_9 5.pdf .
  • 42. Özkan S, Kocaman G, Öztürk C. Çocuklarda Ilaç Uygulama Hatalarının Önlenmesine Yönelik Yöntemlerin Etkinliği. Türk Ped Arş. 2013;48:299-302. [CrossRef
APA SARI Ç, Altay N (2022). Pharmacotherapy and Nursing Approaches in Neonates. , 250 - 256. 10.5152/jern.2022.83704
Chicago SARI ÇİĞDEM,Altay Naime Pharmacotherapy and Nursing Approaches in Neonates. (2022): 250 - 256. 10.5152/jern.2022.83704
MLA SARI ÇİĞDEM,Altay Naime Pharmacotherapy and Nursing Approaches in Neonates. , 2022, ss.250 - 256. 10.5152/jern.2022.83704
AMA SARI Ç,Altay N Pharmacotherapy and Nursing Approaches in Neonates. . 2022; 250 - 256. 10.5152/jern.2022.83704
Vancouver SARI Ç,Altay N Pharmacotherapy and Nursing Approaches in Neonates. . 2022; 250 - 256. 10.5152/jern.2022.83704
IEEE SARI Ç,Altay N "Pharmacotherapy and Nursing Approaches in Neonates." , ss.250 - 256, 2022. 10.5152/jern.2022.83704
ISNAD SARI, ÇİĞDEM - Altay, Naime. "Pharmacotherapy and Nursing Approaches in Neonates". (2022), 250-256. https://doi.org/10.5152/jern.2022.83704
APA SARI Ç, Altay N (2022). Pharmacotherapy and Nursing Approaches in Neonates. Journal of education and research in nursing (Online), 19(2), 250 - 256. 10.5152/jern.2022.83704
Chicago SARI ÇİĞDEM,Altay Naime Pharmacotherapy and Nursing Approaches in Neonates. Journal of education and research in nursing (Online) 19, no.2 (2022): 250 - 256. 10.5152/jern.2022.83704
MLA SARI ÇİĞDEM,Altay Naime Pharmacotherapy and Nursing Approaches in Neonates. Journal of education and research in nursing (Online), vol.19, no.2, 2022, ss.250 - 256. 10.5152/jern.2022.83704
AMA SARI Ç,Altay N Pharmacotherapy and Nursing Approaches in Neonates. Journal of education and research in nursing (Online). 2022; 19(2): 250 - 256. 10.5152/jern.2022.83704
Vancouver SARI Ç,Altay N Pharmacotherapy and Nursing Approaches in Neonates. Journal of education and research in nursing (Online). 2022; 19(2): 250 - 256. 10.5152/jern.2022.83704
IEEE SARI Ç,Altay N "Pharmacotherapy and Nursing Approaches in Neonates." Journal of education and research in nursing (Online), 19, ss.250 - 256, 2022. 10.5152/jern.2022.83704
ISNAD SARI, ÇİĞDEM - Altay, Naime. "Pharmacotherapy and Nursing Approaches in Neonates". Journal of education and research in nursing (Online) 19/2 (2022), 250-256. https://doi.org/10.5152/jern.2022.83704